Anaveon announces presentation of a novel development compound at the 2023 American Association for…
<!-- Name:DistributionId Value:8793595 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4577 -->…
Browsing Tag
Anaveon
Anaveon doses first patient in a Phase I/II Study of ANV419 as monotherapy or in combination with…
<!-- Name:DistributionId Value:8741179 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4577 -->…